Area of research
Genetics · Surgery
Research interest
Research interests include Mesenchymal stem cell research, Tissue Engineering and Regenerative Medicine, Pluripotent Stem Cells Research, and Chronic Kidney Disease and Diabetes.
Long term event-free survival following cell-based therapy in patients with cardiomyopathy: the HYPERION observational cohort
Optimizing the Design and Analysis of Future AKI Trials
A Phase <scp>II</scp> study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the <scp>CCTRN CONCERT‐HF</scp> trial
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction
Demographic representation in clinical trials for cell-based therapy
The impact of patient sex on the response to intramyocardial mesenchymal stem cell administration in patients with non-ischaemic dilated cardiomyopathy
The role of mesenchymal stem/stromal cells in the acute clinical setting
Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit <sup>+</sup> Cardiac Stem Cells As Regenerative Therapy for Heart Failure)
Mesenchymal Stem Cell Therapy for Aging Frailty
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
Physiological and hypoxic oxygen concentration differentially regulates human c-Kit<sup>+</sup> cardiac stem cell proliferation and migration
Tele-Nephrology: A Feasible Way to Improve Access to Care for Patients with Kidney Disease Who Reside in Underserved Areas
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?
Clinical Research Skills Development Program in Cell-Based Regenerative Medicine
The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials
Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy
Link between the renin–angiotensin system and insulin resistance: Implications for cardiovascular disease
Dynamic denitrosylation via <i>S</i> -nitrosoglutathione reductase regulates cardiovascular function
Cell-based therapy for prevention and reversal of myocardial remodeling
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Genetics · Surgery →